Share 'Anthem Revises Policy for EXONDYS 51, Deemed Medically Necessary for Ambulatory Patients'

Progress! Today, Anthem issued a revised policy regarding Sarepta’s EXONDYS 51. In the revision, Anthem declared EXONDYS 51 medically necessary for the treatment of Duchenne muscular dystrophy when all of the following criteria are met: Individual has a confirmed diagnosis of Duchenne muscular dystrophy; and Individual must be ambulatory (with or without needing an assistive device, such as a c…